INGN Stock Analysis: Buy, Sell, or Hold?

INGN - Inogen Inc

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
$6.38
-0.42 (-6.18%) ▼
5d: -9.12%
30d: -3.19%
90d: +10.76%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026 0d
Smart Money Accumulation

INGN is down 9.1% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 162 OI. Call ratio: 100% View Scanner →

Strength: 9.6/10

Get Alerted When INGN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: INGN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: INGN is currently trading at $6.38, which is considered oversold relative to its 30-day fair value range of $6.54 to $7.15. From a valuation perspective, the stock is trading at a discount (Forward PE: -24.5) compared to its historical average (120.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, INGN is in a uptrend. The price is currently testing key support at $6.37. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.67 (+98.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $6.54 - $7.15
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 83.5%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.2%)
  • BULLISH: Trading 98.5% below Wall St target ($12.67)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • CAUTION: Recommendation downgraded due to -9.1% 5-day decline

Trading Range Analysis

30-Day Trading Range $6.54 - $7.15
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$0.45 (7.0%)

Support & Resistance Levels

Support Level $6.37
Resistance Level $7.43
Current Trend Uptrend
Technical data as of May 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) -24.54
Wall Street Target $12.67 (+98.5%)
Revenue Growth (YoY) 3.4%
Earnings Growth (YoY) 87.3%
Profit Margin -7.1%
PE vs Historical -24.5 vs 120.2 CHEAP
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for INGN.

Create Free Account

Already have an account? Log In

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BSX
Boston Scientific Corp
STRONG BUY
34 analysts
$85 59 HOLD
DXCM
DexCom Inc
STRONG BUY
26 analysts
$83 66 BUY
MDT
Medtronic PLC
BUY
32 analysts
$108 64 BUY
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$97 55 HOLD
ZBH
Zimmer Biomet Holdings I…
HOLD
29 analysts
$99 62 BUY

More Analysis for INGN

INGN Technical Chart INGN Price Prediction INGN Earnings Date INGN Investment Advisor INGN Fair Price Analyzer INGN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals